glp-1 hypothalamus Nature: Dual-active molecules targeting GLP-1R and NMDA receptors exhibit superior anti-obesity effects Frontiers | Mechanisms of action

A 2026 systematic review in the European Journal of Endocrinology found GLP-1 receptor agonists were associated with modest short-term weight loss in women with PCOS and overweight or obesity

S., Elshal, M

This class of drugs has a variety of actions, the researchers wrote, including those that affect inflammation and insulin sensitivity, which makes them useful tools for managing diabetes and preventing eye disorders. Specific to glaucoma risk, underlying mechanisms of GLP-1 agonist use involve enhancement of insulin sensitivity, reduction of inflammation and promotion of neuroprotection

You will be a bit red leaving your appointment, but that will fade over the next 24 hours